1. Understanding and Addressing the Needs of Patients With AD

3. Introduction

4. Signs and Symptoms of AD

5. Epidemiology of AD

6. AD Severity Distribution

7. AD Etiology

8. Comorbidity

9. Disease Burden of AD

10. Impact of Mild-to-Moderate AD

11. Impact of Mild-to-Moderate AD (cont)

12. Treatment Recommendations: Adults

13. Treatment Recommendations: Children

14. Emollients

15. Topical Corticosteroids: Limitations

16. Topical Calcineurin Inhibitors

17. Challenges in Patients With Mild-to-Moderate AD -- Expert Perspective

18. Factors Contributing to Poor Adherence[a-c]

19. TCS Phobia

20. TCS Phobia (cont)

21. What Is Therapeutic Patient Education?

22. Therapeutic Patient Education: Objectives

23. Milestones in the Treatment of AD[a-c]

24. Topical PDE4 Inhibitors

25. Emerging Therapies for Mild-to-Moderate AD -- Expert Perspective

26. Management of Pediatric Patients With Mild-to-Moderate AD

27. Management of S aureus Infection in Pediatric Patients With Mild-to-Moderate AD

28. Concluding Remarks

29. Abbreviations